NDC Package 0069-1415-02 Panzyga

Immune Globulin Intravenous (human) Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0069-1415-02
Package Description:
1 BOTTLE, GLASS in 1 CARTON / 200 mL in 1 BOTTLE, GLASS (0069-1415-01)
Product Code:
Proprietary Name:
Panzyga
Non-Proprietary Name:
Immune Globulin Intravenous (human)
Substance Name:
Human Immunoglobulin G
Usage Information:
This medication is used to strengthen the body's natural defense system (immune system) to lower the risk of infection in persons with a weakened immune system. This medication is made from healthy human blood that has a high level of certain defensive substances (antibodies), which help fight infections. It is also used to increase the blood count (platelets) in persons with a certain blood disorder (idiopathic thrombocytopenia purpura-ITP). Platelets are needed to stop bleeding and form blood clots. Some immune globulin products may also be used to treat a certain type of muscle weakness problem (multifocal motor neuropathy) or a certain nerve disorder (chronic inflammatory demyelinating polyneuropathy-CIDP). Some products may also be used to prevent certain blood vessel disorders in people with Kawasaki syndrome.
11-Digit NDC Billing Format:
00069141502
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2102435 - immune globulin intravenous (human) - ifas 10 % in 10 ML Injection
  • RxCUI: 2102435 - 10 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection
  • RxCUI: 2102435 - immune globulin intravenous (human) - ifas 10 % per 10 ML Injection
  • RxCUI: 2102440 - panzyga 10 % in 10 ML Injection
  • RxCUI: 2102440 - 10 ML immune globulin intravenous (human) - ifas 100 MG/ML Injection [Panzyga]
  • Product Type:
    Plasma Derivative
    Labeler Name:
    Pfizer Laboratories Div Pfizer Inc
    Dosage Form:
    Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    BLA125587
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    08-09-2019
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0069-1415-02 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00069141502J1576Inj, panzyga, 500 mg500 MG20014040

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0069-1415-02?

    The NDC Packaged Code 0069-1415-02 is assigned to a package of 1 bottle, glass in 1 carton / 200 ml in 1 bottle, glass (0069-1415-01) of Panzyga, a plasma derivative labeled by Pfizer Laboratories Div Pfizer Inc. The product's dosage form is solution and is administered via intravenous form.

    Is NDC 0069-1415 included in the NDC Directory?

    Yes, Panzyga with product code 0069-1415 is active and included in the NDC Directory. The product was first marketed by Pfizer Laboratories Div Pfizer Inc on August 09, 2019 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0069-1415-02?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 0069-1415-02?

    The 11-digit format is 00069141502. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20069-1415-025-4-200069-1415-02